Case Report
A 57-year-old female with history of dysphagia, alcohol abuse, and gallstone pancreatitis status post cholecystectomy 4 years ago was transferred for evaluation of cholangitis. IPMN was seen on EUS/ERCP (Figures 1, 2) . EUS/ERCP also demonstrated a common bile duct measuring 23 mm, pancreas divisum with 10 mm duct of Santorini, and a transient mucin globule. The mucin ball is also seen floating in the pancreatic duct (Video clip). Pancreatic juice aspiration demonstrated atypical glandular cells and mucin compatible with IPMN. The atypical glandular cells show features of low-moderate dysplasia. On MRI, pancreas divisum is evident, as well as a dilated duct (Figures 3, 4) . Patient is not a surgical candidate given her liver disease and was instead observed. She was recommended to abstain from alcohol and reduce narcotic pain medication. She will be reevaluated in 2 to 3 months with nuclear medicine liver SPECT scan.
Discussion
IPMN of the pancreas include features of ductal dilation, intraductal papillary growth, and thick mucus secretion. They develop from the pancreatic duct epithelium in the main pancreatic duct or its branches and have malignant potential. IPMN accounts for 7.5% of clinically diagnosed pancreatic neoplasms and 16.3-25% of surgically resected pancreatic neoplasms [7] . The risk of malignancy for main duct IPMN is significant, ranging from 57% to 92% compared to branch duct IPMN, which has a risk of malignancy from 6% to 46% [7] .
PD has been seen with pancreatitis and pancreatic neoplasms, but rarely with IPMN. In a retrospective single-center study, only 5% of patients with PD had IPMN [8] . In a recent case report and review of the literature, only 16 cases of IPMN associated with pancreas divisum, including our case, were identified. More than half of the patients reported had branch-duct type IPMN [2] .
Main duct IPMN is associated with increased risk of malignant transformation and dilation of >10 mm has an even higher risk of malignancy [7] . In this report, the IPMN is in the main pancreatic duct and measures 10 mm and therefore, this patient has increased risk of malignant transformation. Surgical intervention is the management of IPMN because of malignant potential. For main duct IPMN specifically, total pancreatectomy is the procedure of choice. This also requires an oncological lymphadenectomy, which compromises the lymph nodes of the hepatoduodenal ligament and surrounding lymph nodes of the celiac axis and superior mesenteric artery. Additionally, reconstruction includes pancreaticojejunostomy or pancreaticogastrostomy, hepaticojejunostomy, and duodeno-or gastrojejunostomy [9] . However, given the patient's cirrhotic morphology, surgery was not recommended because of the potential for liver failure.
IPMN accounts for 5.1% of pancreatic carcinomas in PD [8] . The mechanism may involve increased incidence of chronic pancreatitis in the setting of IPMN [10] . However, the relationship between IPMN and PD is unclear. Given the patient's complicated history, the implications of PD and main duct IPMN in her past presentation of pancreatitis are uncertain. However, this case demonstrates the importance of familiarity with this anatomic variation and recognition of IPMN on imaging for appropriate management and prevention of malignant transformation.
Conclusion
Recognition of PD and its potential complications are critical in appropriate management of patients presenting with a history of pancreatitis. Although the relationship between PD and IPMN is unclear, this case supports the importance of further elucidating the mechanism by which IPMN develops in the setting of PD.
